SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1569 8041 OR L773:0923 7534 srt2:(2020-2024)"

Sökning: L773:1569 8041 OR L773:0923 7534 > (2020-2024)

  • Resultat 1-10 av 177
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Browall, Maria, et al. (författare)
  • Digi-Do : A digital information tool to support patients with breast cancer before, during, and after start of radiotherapy treatment
  • 2020
  • Ingår i: Annals of Oncology. - : Elsevier. - 0923-7534 .- 1569-8041. ; 31:Supplement 4, s. S1126-S1126
  • Tidskriftsartikel (refereegranskat)abstract
    • Radiation Therapy (RT) is a common treatment after breast cancer surgery. The high-tech environment and unfamiliar nature of RT can affect the patient’s experience of the treatment. Misconceptions or a lack of knowledge about RT processes can increase levels of anxiety and enhance feelings of being unprepared at the beginning of treatment. Moreover, the waiting time can be long and experienced as meaningless or even life threatening. For successful radiotherapy, the person often needs to be immobilized. A calm, well informed patient might enhance quality of treatment, both from patient and provider perspective. Waiting times can become meaningful instead of meaningless if used wisely for information and preparation for patients and loved ones.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Derksen, J. W. G., et al. (författare)
  • Real-world evidence contributions to European medicines agency's safety and efficacy evaluations of oncology targeted therapies between 2018-2022
  • 2023
  • Ingår i: Annals of Oncology. - : Elsevier. - 0923-7534 .- 1569-8041. ; 34:Suppl. 2, s. S930-S930
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Background: While Real-world Evidence (RWE) has documented value for safety monitoring and disease epidemiology, its objective contribution to safety and efficacy evaluations for regulatory purposes is still unclear. Here, we aim to describe the prevalence and type of RWE considered by European Medicines Agency (EMA) as contribution to efficacy and safety-related evidence generation among approved oncology targeted therapies...Methods: On March 10, 2023, we screened the medicines listing of EMA to identify all anti-cancer targeted therapies for solid malignancies with a decision date (initial marketing authorizations and extension of indications) between 2018-2022. We screened the European public assessment reports (EPARs) using a standardized approach to collect data on RWE. When generated pre-authorization, the RWE contribution to the final regulatory decision was classified as definitive, supportive, or non-supportive. For...Results: Out of a total of 1976 medicines, we identified 55 oncology targeted therapies, corresponding to 75 EPARs (indications), which are described in the table. The use of RWE in regulatory deliberations occurred in 24/75 (32%) EPARs, increasing from 30% in 2018-2020, to 34% in 2021-2022. Pre-authorization RWE was described in 20/24 (83%) EPARs, among which none were definitive, 8 RWE studies (in 7 EPARs) non-supportive, and 20 RWE studies (in 15 EPARs) were supportive of the decision. Published RWE...Conclusions: Over the past 5 years, RWE involvement in the approval of oncology targeted therapies in Europe tends to increase, with the majority being supportive for EMA regulatory decision making complementary to traditional clinical trials...
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 177
Typ av publikation
konferensbidrag (101)
tidskriftsartikel (74)
forskningsöversikt (2)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (125)
refereegranskat (52)
Författare/redaktör
Bergh, J (14)
Harbeck, N (8)
Cardoso, F (8)
Denkert, C (8)
Schmid, P. (7)
Rutkowski, P (7)
visa fler...
Helgadottir, H (7)
Eriksson, H (6)
Czene, K (6)
Hartman, J (6)
Delaloge, S (6)
Lebbe, C (6)
Loibl, S (6)
Wengstrom, Y. (6)
Mandala, M (6)
Takahashi, M. (5)
Gnant, M. (5)
O'Shaughnessy, J (5)
Eriksson, M (5)
Nilsson, M (5)
Glimelius, B (5)
Fasching, PA (5)
Fang, F (5)
Sorbye, H. (5)
Poortmans, P (5)
Vogel, A. (4)
Robertson, S. (4)
Moller, S (4)
Hatschek, T (4)
Adami, HO (4)
Fredriksson, I (4)
Lindman, H (4)
Viale, G (4)
Berglund, A. (4)
Lindstrom, L (4)
Untch, M (4)
Lordick, F. (4)
Guida, M. (4)
Lehtio, J (4)
Melero, I (4)
Backman, M. (4)
Ascierto, PA (4)
Ferrucci, PF (4)
Guidoboni, M (4)
Ferraresi, V (4)
Maiello, E (4)
Fierro, MT (4)
Palmieri, G (4)
Giannarelli, D (4)
Grimaldi, AM (4)
visa färre...
Lärosäte
Karolinska Institutet (146)
Örebro universitet (10)
Uppsala universitet (8)
Lunds universitet (7)
Göteborgs universitet (6)
Umeå universitet (5)
visa fler...
Jönköping University (3)
Linköpings universitet (2)
Karlstads universitet (2)
Högskolan Kristianstad (1)
Mälardalens universitet (1)
Handelshögskolan i Stockholm (1)
Mittuniversitetet (1)
Chalmers tekniska högskola (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (177)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (43)
Samhällsvetenskap (2)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy